Scientific Pilot Awards support early-career investigators conducting site-based HIV immunology and vaccinology research to advance their scientific careers and strengthen HVTN collaborations.
Funder: HIV Vaccine Trials Network
Due Dates (Anticipated): September 2027 (Application deadline)
Funding Amounts: Up to $35,000 in direct costs for 12 months; 4–6 awards anticipated
Summary: Supports early-career investigators conducting site-based HIV immunology and vaccinology research that advances their careers and HVTN collaborations.
Key Information: Applicants need affiliation with an HVTN Core Site or actively enrolling site and a designated site mentor.
The HIV Vaccine Trials Network (HVTN) Scientific Pilot Awards support early-career investigators who have already published first-author manuscripts to conduct research at their sites. Projects must focus on HIV immunology or vaccinology, advance the investigator’s scientific career development—for example, by generating preliminary data—and strengthen collaborations with HVTN laboratories or statistical teams. Using HVTN specimens or data is encouraged but not required.
Priority ideas draw on the Cross-Protocol Study Initiative and address antibody and B cell integration, neutralizing antibody relationships, and T cell responses associated with antibody induction. Original proposals beyond these topics are also supported, including basic science and laboratory research that advances HVTN priorities and can be completed within one year. Qualitative and sociobehavioral research will not be considered.